SE8701765D0 - Analysis method and means therefor - Google Patents

Analysis method and means therefor

Info

Publication number
SE8701765D0
SE8701765D0 SE8701765A SE8701765A SE8701765D0 SE 8701765 D0 SE8701765 D0 SE 8701765D0 SE 8701765 A SE8701765 A SE 8701765A SE 8701765 A SE8701765 A SE 8701765A SE 8701765 D0 SE8701765 D0 SE 8701765D0
Authority
SE
Sweden
Prior art keywords
virus
disclosed
analysis method
means therefor
related human
Prior art date
Application number
SE8701765A
Other languages
English (en)
Other versions
SE8701765L (sv
Original Assignee
Statens Bakteriologiska Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Bakteriologiska Lab filed Critical Statens Bakteriologiska Lab
Priority to SE8701765A priority Critical patent/SE8701765L/sv
Publication of SE8701765D0 publication Critical patent/SE8701765D0/sv
Priority to PCT/SE1988/000218 priority patent/WO1988008449A1/en
Priority to AU17110/88A priority patent/AU1711088A/en
Publication of SE8701765L publication Critical patent/SE8701765L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8701765A 1987-04-28 1987-04-28 Analysmetod och medel foer denna SE8701765L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna
PCT/SE1988/000218 WO1988008449A1 (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof
AU17110/88A AU1711088A (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna

Publications (2)

Publication Number Publication Date
SE8701765D0 true SE8701765D0 (sv) 1987-04-28
SE8701765L SE8701765L (sv) 1988-10-29

Family

ID=20368350

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna

Country Status (3)

Country Link
AU (1) AU1711088A (sv)
SE (1) SE8701765L (sv)
WO (1) WO1988008449A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369427A3 (en) * 1988-06-09 2004-05-12 Innogenetics N.V. HIV-3 retrovirus strains and their use
US5223423A (en) * 1989-03-31 1993-06-29 United States Of America Characterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isy
EP0400245B1 (en) * 1989-05-31 1995-12-20 Institut Pasteur Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies directed against them - application for the diagnosis
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
FR2576107B1 (fr) * 1985-01-15 1990-08-31 Cancer Res Inst Procede de recherche d'anticorps et equipement ou kit pour la mise en oeuvre de ce procede
EP0249611A4 (en) * 1985-11-14 1988-04-26 Harvard College T-LYMPHOTROPHIC VIRUS.
ATE47725T1 (de) * 1986-01-22 1989-11-15 Pasteur Institut Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile.
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses

Also Published As

Publication number Publication date
SE8701765L (sv) 1988-10-29
AU1711088A (en) 1988-12-02
WO1988008449A1 (en) 1988-11-03

Similar Documents

Publication Publication Date Title
Osterhaus et al. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
NO169844C (no) Htlv-iii (env)-peptider
BR9305435A (pt) Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
ES553757A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
SE8701765D0 (sv) Analysis method and means therefor
Falkler Jr et al. Human antibody to dengue soluble complement-fixing (SCF) antigens
ES2056075T3 (es) Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.
FI95871B (sv) Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу
LIU et al. Preparation of refined antimeasles gamma globulin from immunized goats and pigs

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701765-3

Effective date: 19901101

Format of ref document f/p: F